-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Baili Tianheng (688506.SH) announced that on December 11, 2023, SystimMune, a wholly-owned subsidiary of the company, and Bristol-Myers Squibb (“BMS”, NYSE code: BMY) reached a global strategic cooperation agreement on the “iza-bren” (iza-bren) project. The company has received an initial payment of $800 million from BMS and the first milestone payment of $250 million between 2024 and 2025.

Zhitongcaijing·11/17/2026 11:25:07
Listen to the news
Zhitong Finance App News, Baili Tianheng (688506.SH) announced that on December 11, 2023, SystimMune, a wholly-owned subsidiary of the company, and Bristol-Myers Squibb (“BMS”, NYSE code: BMY) reached a global strategic cooperation agreement on the “iza-bren” (iza-bren) project. The company has received an initial payment of $800 million from BMS and the first milestone payment of $250 million between 2024 and 2025.